Abdominal Sacral Resection for Posterior Pelvic Recurrence of Rectal Carcinoma: Analyses of Prognostic Factors and Recurrence Patterns

Aoki, Takayuki; Yamaguchi, Takashi; Fujimoto, Yoshiya; Ishiguro, Seiji; Yamamoto, Seiichiro; Fujita, Shin; Moriya, Yoshihiro

doi:10.1245/s10434-006-9082-0

Cited by 48 publications

(35 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…After screening, 16 studies were found to be eligible for inclusion (1 prospective cohort study on radiosurgery (level II) [32]; 2 case series (level III) [28,33]; 4 retrospective case series (level IV) [2,10,34,35] and 9 case reports (level IV) [36][37][38][39][40][41][42][43][44]; Table 1). …”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Management of metastatic sacral tumours

et al. 2012

View full text Add to dashboard Cite

Purpose Metastatic involvement of the sacrum is rare and there is a paucity of studies which deal with the management of these tumours since most papers refer to primary sacral tumours. This study aims to review the available literature in the management of sacral metastatic tumours as reflected in the current literature. Methods A systematic review of the English language literature was undertaken for relevant articles published over the last 11 years (1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008)(2009)(2010). The PubMed electronic database and reference lists of key articles were searched to identify relevant studies using the terms ''sacral metastases'' and ''metastatic sacral tumours''. Studies involving primary sacral tumours only were excluded. For the assessment of the level of evidence quality, the CEBM (Oxford Centre of Evidence Based Medicine) grading system was utilised. Results The initial search revealed 479 articles. After screening, 16 articles identified meeting our inclusion criteria [1 prospective cohort study on radiosurgery (level II); 2 case series (level III); 4 retrospective case series (level IV) and 9 case reports (level IV)]. Conclusion The mainstay of management for sacral metastatic tumours is palliation. Preoperative angioembolisation is shown to be of value in cases of highly vascularised tumours. Radiotherapy is used as the primary treatment in cases of inoperable tumours without spinal instability where pain relief and neurological improvement are attainable. Minimal invasive procedures such as sacroplasties were shown to offer immediate pain relief and improvement with ambulation, whereas more aggressive surgery, involving decompression and sacral reconstruction, is utilised mainly for the treatment of local advanced tumours which compromise the stability of the spine or threaten neurological status. Adjuvant cryosurgery and radiosurgery have demonstrated promising results (if no neurological compromise or instability) with local disease control.

show abstract

Section: Resultsmentioning

confidence: 99%

“…Six studies report on their results of surgery ranging from posterior decompression with(out) cementation and instrumentation [2,28,35,43] to abdominal sacral resection [33] and en bloc sacrectomy [34,44].…”

Section: Treatmentmentioning

confidence: 99%

Management of metastatic sacral tumours

et al. 2012

View full text Add to dashboard Cite

show abstract

“…Это значит, что паллиативные вмешательства не должны рассматриваться как единственный вари-ант терапии данной когорты больных. Радикальность проведенной операции является важнейшим прогно-стическим фактором как для местно-распространен-ных, так и для рецидивных опухолей прямой кишки и достоверно коррелирует с частотой развития мест-ного рецидива [2][3][4]. В настоящее время, по данным разных авторов, в 52-76 % случаев возможно выпол-нение радикальной (R0) абдоминосакральной резек-ции (АСР) [1,5,6].…”

Section: ключевые слова: рак прямой кишки местно-распространенный раunclassified

Abdominosacral resection in the surgical treatment of rectal cancer

Карачун¹,

Gafton²,

Самсонов³

et al. 2015

Onkol. koloproktol.

View full text Add to dashboard Cite

“…Hazard Ratio (95% CI) P Em que pese à alta morbidade da exenteração pélvica, essa é a única oportunidade de controle da doença em longo prazo, haja vista que os demais tratamentos têm apresentado resultados desalentadores (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19).…”

Section: Tabela 7 -Análise Univariada De Fatores Prognósticosunclassified

“…Apresentam freqüências variáveis nas diferentes séries descritas. Estima-se que entre 6 e 10% de todas as neoplasias retais se encontrem no estádio T4 no momento de seu diagnóstico (1)(2)(3). Por outro lado, as recidivas pélvicas após cirurgia potencialmente curativa têm variado de 4 a 50% (4)(5)(6)(7)(8).…”

Section: Introductionunclassified

A exenteração pélvica para o câncer de reto: avaliação dos fatores prognósticos de sobrevida em 27 pacientes operados

Costa

Teixeira

Lupinacci

2008

Rev bras. colo-proctol.

View full text Add to dashboard Cite

INTRODUÇÃOO câncer de reto localmente avançado (T4) bem como a recidiva pélvica isolada representam situações clínicas desafiadoras na prática clínica diária. Ambas as condições condenam o doente a um sofrimento atroz e duradouro, comprometendo seriamente tanto sua sobrevida em longo prazo quanto sua própria qualidade de vida. Apresentam freqüências variáveis nas diferentes séries descritas. Estima-se que entre 6 e 10% de todas as neoplasias retais se encontrem no estádio T4 no momento de seu diagnóstico (1-3). Por

show abstract

Abdominal Sacral Resection for Posterior Pelvic Recurrence of Rectal Carcinoma: Analyses of Prognostic Factors and Recurrence Patterns

Cited by 48 publications

References 33 publications

Management of metastatic sacral tumours

Management of metastatic sacral tumours

Abdominosacral resection in the surgical treatment of rectal cancer

A exenteração pélvica para o câncer de reto: avaliação dos fatores prognósticos de sobrevida em 27 pacientes operados

Contact Info

Product

Resources

About